US Stocks
/
Insight Molecular Diagnostics Inc. Share Price

Insight Molecular Diagnostics Inc. Share Price

NASDAQ: IMDX | Micro Cap
$3.37
+$0.09 (2.74%) Last updated on 10 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Insight Molecular Diagnostics Inc. Stock Performance

Open
$3.29
Prev. Close
$3.28
Circuit Range
N/A
Day Range
$3.23 - $3.38
Year Range
$2.42 - $8.49
Volume
10,472
Average Traded
$3.34

Insight Molecular Diagnostics Inc. Share Price Today

As of 11 October 2026, Insight Molecular Diagnostics Inc.'s share price is $3.37. The stock opened at $3.29, compared to its previous close of $3.28. During today's trading session, Insight Molecular Diagnostics Inc.'s share price traded between $3.23 and $3.38, with an average price of $3.30. Over the past 52 weeks, the stock has recorded a high of $8.49 and a low of $2.42. In terms of performance, Insight Molecular Diagnostics Inc.'s share price has declined by 14.90% over the last six months and is down 44.39% on a year-on-year basis.

Insight Molecular Diagnostics Inc. Share Price Chart

$3.23$3.38
L
Show Current Price
H

Insight Molecular Diagnostics Inc. Stock Fundamentals & Key Indicators

Market Cap
$102.70M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.51
Revenue (TTM)
$4.06B
Return On Equity (TTM)
231.74%
Profit Margin
-1236.95%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-3.78%

Insight Molecular Diagnostics Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.26$1.14$0.03$0.24
Net Profit-$10.85-$22.96-$4.29-$11.26
Net Profit Margin-4173.08%-2014.04%-14300.00%-4691.67%
Income ChangeN/A-111.61%81.32%-162.47%

Insight Molecular Diagnostics Inc. Annual Profit & Loss

All figures in USD

Particulars2025
Revenue$4.06
Net Profit-$50.22
Net Profit Margin-1236.95%
Income ChangeN/A

About Insight Molecular Diagnostics Inc.

Insight Molecular Diagnostics Inc is a pioneering diagnostics technology company whose mission is to democratize access to novel molecular diagnostic testing to improve patient outcomes. The Company's flagship technology quantifies a molecular biomarker known as donor-derived cell-free DNA (dd-cfDNA). It is also in the process of rebranding its RUO test kit, GraftAssure, as GraftAssureIQ, and rebranding its future in-vitro diagnostic (IVD) test kit as GraftAssureDx. The company geographically operates in the United States, the United Kingdom, Europe, and the Asia-Pacific regions, with maximum revenue generated from the USA.

Insight Molecular Diagnostics Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$3.37
$3.38
-6.12%
Sep 2026
$3.82
$3.60
-15.81%
Aug 2026
$4.90
$4.27
-8.57%
Jul 2026
$5.74
$4.67
-20.03%
Jun 2026
$6.21
$5.84
-6.41%
May 2026
$3.99
$6.24
+57.58%
Apr 2026
$3.03
$3.96
+20.73%
Mar 2026
$5.83
$3.28
-45.24%
Feb 2026
$6.79
$5.99
-9.79%
Jan 2026
$7.27
$6.64
-11.58%
Dec 2025
$5.81
$7.51
+22.71%
Nov 2025
$5.95
$6.12
+0.99%

IMDX Share Price FAQs

What is Insight Molecular Diagnostics Inc. share price today?

chevron-up
Insight Molecular Diagnostics Inc. share price today is $3.37 as on October 10, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Insight Molecular Diagnostics Inc. stock?

chevron-up
The 52 week high of Insight Molecular Diagnostics Inc. stock is $8.49, while the 52 week low is $2.42 as of 10 Oct '26.

What is IMDX's market capitalisation today?

chevron-up
IMDX market capitalisation is $102.70M as of October 11, 2026, at 2:05 am IST.

What is IMDX's net income for the last quarter?

chevron-up
IMDX's net income for the last quarter is -11.26B USD.

What is the 5 year returns of IMDX?

chevron-up
The 5 year returns of IMDX is -94.86% as on 10 Oct '26.

What is the high & low stock price of IMDX today?

chevron-up
IMDX stock price hit a high of $3.38 and low of $3.23 as of 10 Oct '26.

Can I buy IMDX shares in India?

chevron-up
Yes. You can buy IMDX in India by opening an international trading account.